Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi : Impact Factor & More
pISSN: 0253-2727
Share this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi Journal Specifications
Indexed in the following public directories
Scopus 
SJR
| Overview | |
| Publisher | Zhongguo Yixue Kexueyuan |
Planning to publish in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Clinical application value of detecting the mutation load of the FLT3-ITD gene before allogeneic hematopoietic stem cell transplantation using PCR-NGS technology
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Chronic myelomonocytic leukemia complicated with T-lymphoblastic lymphoma: a case report and literature review
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
How I manage relapsed/refractory B-cell acute lymphoblastic leukemia patients treated with CD19 CAR- T cells throughout whole-process management
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Multiple myeloma with massive proliferation of signet ring cell like plasma cells: a case report
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Chinese expert consensus on the diagnosis and management of nodal peripheral T-cell lymphoma (2025)
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Effect of different induction chemotherapy regimens on autologous hematopoietic stem cell mobilization in patients with multiple myeloma in the new drug era
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Clinical application value of detecting the mutation load of the FLT3-ITD gene before allogeneic hematopoietic stem cell transplantation using PCR-NGS technology
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Chronic myelomonocytic leukemia complicated with T-lymphoblastic lymphoma: a case report and literature review
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
How I manage relapsed/refractory B-cell acute lymphoblastic leukemia patients treated with CD19 CAR- T cells throughout whole-process management
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Multiple myeloma with massive proliferation of signet ring cell like plasma cells: a case report
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Chinese expert consensus on the diagnosis and management of nodal peripheral T-cell lymphoma (2025)
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Effect of different induction chemotherapy regimens on autologous hematopoietic stem cell mobilization in patients with multiple myeloma in the new drug era
- 14 Dec 2025
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
FAQs on Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
How many articles did Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi publish last year? 
Who is the publisher of Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi?
